PFBT
EDIT icon

Parkside Financial Bank & Trust’s Editas Medicine EDIT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01K Hold
410
– – ﹤0.01% 2352
2025
Q4 		$841 Hold
410
– – ﹤0.01% 2396
2025
Q3 		$1.42K Hold
410
– – ﹤0.01% 2145
2025
Q2 		$902 Buy
+410
New +$671 ﹤0.01% 2302

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parkside Financial Bank & Trust's EDIT Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Editas Medicine (EDIT) position steady in Q1 2026 at 410 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

Parkside Financial Bank & Trust first reported a position in EDIT in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.42K in Q3 2025. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Parkside Financial Bank & Trust held 410 shares of Editas Medicine worth $1.01K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Editas Medicine share count unchanged in Q1 2026.
  • Editas Medicine made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2352 holding.
  • Parkside Financial Bank & Trust first reported a position in Editas Medicine in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Editas Medicine position peaked at $1.42K in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.